ITFI20050206A1 - Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione - Google Patents

Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione

Info

Publication number
ITFI20050206A1
ITFI20050206A1 IT000206A ITFI20050206A ITFI20050206A1 IT FI20050206 A1 ITFI20050206 A1 IT FI20050206A1 IT 000206 A IT000206 A IT 000206A IT FI20050206 A ITFI20050206 A IT FI20050206A IT FI20050206 A1 ITFI20050206 A1 IT FI20050206A1
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
preparation
controlled release
venlafaxine
chloridrate
Prior art date
Application number
IT000206A
Other languages
English (en)
Inventor
Tiziano Alighieri
Serozh Avanessian
Roberto Valducci
Original Assignee
Valpharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valpharma Sa filed Critical Valpharma Sa
Priority to IT000206A priority Critical patent/ITFI20050206A1/it
Priority to NZ567735A priority patent/NZ567735A/en
Priority to AU2006298693A priority patent/AU2006298693A1/en
Priority to CA002622822A priority patent/CA2622822A1/en
Priority to EP06819063A priority patent/EP1928424B1/en
Priority to JP2008532796A priority patent/JP2009510027A/ja
Priority to BRPI0616276-2A priority patent/BRPI0616276A2/pt
Priority to CNA2006800325469A priority patent/CN101257893A/zh
Priority to KR1020087006551A priority patent/KR20080047557A/ko
Priority to US11/992,285 priority patent/US20090263471A1/en
Priority to RU2008117111/15A priority patent/RU2423105C2/ru
Priority to AT06819063T priority patent/ATE521339T1/de
Priority to ES06819063T priority patent/ES2373164T3/es
Priority to PCT/EP2006/066906 priority patent/WO2007039569A2/en
Publication of ITFI20050206A1 publication Critical patent/ITFI20050206A1/it
Priority to IL190305A priority patent/IL190305A0/en
Priority to NO20081733A priority patent/NO20081733L/no
Priority to ZA200803502A priority patent/ZA200803502B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT000206A 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione ITFI20050206A1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT000206A ITFI20050206A1 (it) 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
CNA2006800325469A CN101257893A (zh) 2005-09-30 2006-09-29 文拉法辛盐酸盐的控释药物组合物及其制备方法
RU2008117111/15A RU2423105C2 (ru) 2005-09-30 2006-09-29 Фармацевтическая композиция с контролируемым высвобождением венлафаксина гидрохлорида и способ ее получения
CA002622822A CA2622822A1 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
EP06819063A EP1928424B1 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
JP2008532796A JP2009510027A (ja) 2005-09-30 2006-09-29 ベンラファキシン塩酸塩の制御放出性の医薬組成物、及びその調製方法
BRPI0616276-2A BRPI0616276A2 (pt) 2005-09-30 2006-09-29 composiÇço farmacÊutica de liberaÇço controlada de cloridrato de venlafaxina e processo de preparaÇço da mesma
NZ567735A NZ567735A (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
KR1020087006551A KR20080047557A (ko) 2005-09-30 2006-09-29 방출 조절형 벤라팍신 히드로클로라이드계 약제학적 조성물및 그의 제조 방법
US11/992,285 US20090263471A1 (en) 2005-09-30 2006-09-29 Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof
AU2006298693A AU2006298693A1 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
AT06819063T ATE521339T1 (de) 2005-09-30 2006-09-29 Pharmazeutische zusammensetzung aus venlafaxin- hydrochlorid mit kontrollierter freisetzung und herstellungsverfahren dafür
ES06819063T ES2373164T3 (es) 2005-09-30 2006-09-29 Composición farmacéutica de liberación controlada de clorhidrato de venlafaxina, y procedimiento para la preparación de la misma.
PCT/EP2006/066906 WO2007039569A2 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
IL190305A IL190305A0 (en) 2005-09-30 2008-03-19 Controlled release, pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
NO20081733A NO20081733L (no) 2005-09-30 2008-04-07 Kontrollert frigjorende farmasoytisk sammensetning av venlafaksinhydroklorid og fremgangsmate for dens fremstilling
ZA200803502A ZA200803502B (en) 2005-09-30 2008-04-21 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000206A ITFI20050206A1 (it) 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione

Publications (1)

Publication Number Publication Date
ITFI20050206A1 true ITFI20050206A1 (it) 2007-04-01

Family

ID=36215990

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000206A ITFI20050206A1 (it) 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione

Country Status (17)

Country Link
US (1) US20090263471A1 (it)
EP (1) EP1928424B1 (it)
JP (1) JP2009510027A (it)
KR (1) KR20080047557A (it)
CN (1) CN101257893A (it)
AT (1) ATE521339T1 (it)
AU (1) AU2006298693A1 (it)
BR (1) BRPI0616276A2 (it)
CA (1) CA2622822A1 (it)
ES (1) ES2373164T3 (it)
IL (1) IL190305A0 (it)
IT (1) ITFI20050206A1 (it)
NO (1) NO20081733L (it)
NZ (1) NZ567735A (it)
RU (1) RU2423105C2 (it)
WO (1) WO2007039569A2 (it)
ZA (1) ZA200803502B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056937T2 (hu) 2006-02-03 2022-04-28 Opko Renal Llc A D-vitamin elégtelenség és hiány kezelése 25-hidroxivitamin D2-vel és 25-hidroxivitamin D3-mal
PT2679228T (pt) 2006-06-21 2018-04-16 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
PT2148684E (pt) 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
KR101959952B1 (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
WO2009124210A1 (en) 2008-04-02 2009-10-08 Cytochroma Inc. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
CN102085197B (zh) * 2010-12-14 2013-08-14 北京万生药业有限责任公司 一种文拉法辛缓释制剂及其制备方法
CN103181916A (zh) * 2011-12-30 2013-07-03 昆明积大制药股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
CA3018019A1 (en) 2016-03-28 2017-10-26 Opko Ireland Global Holdings, Limited Methods of vitamin d treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
CA2507685A1 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci

Also Published As

Publication number Publication date
RU2008117111A (ru) 2009-11-10
CA2622822A1 (en) 2007-04-12
AU2006298693A1 (en) 2007-04-12
RU2423105C2 (ru) 2011-07-10
US20090263471A1 (en) 2009-10-22
ZA200803502B (en) 2009-01-28
IL190305A0 (en) 2009-09-22
NZ567735A (en) 2011-03-31
JP2009510027A (ja) 2009-03-12
KR20080047557A (ko) 2008-05-29
WO2007039569A2 (en) 2007-04-12
ES2373164T3 (es) 2012-02-01
ATE521339T1 (de) 2011-09-15
EP1928424A2 (en) 2008-06-11
CN101257893A (zh) 2008-09-03
BRPI0616276A2 (pt) 2011-06-14
NO20081733L (no) 2008-04-07
WO2007039569A3 (en) 2007-07-26
EP1928424B1 (en) 2011-08-24

Similar Documents

Publication Publication Date Title
ITFI20050206A1 (it) Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
AR116052A2 (es) Forma cristalina de clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
AR049083A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
PE20060195A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
BRPI0409652A (pt) tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete
ECSP077243A (es) Formulación de pelet de liberación extendida que contiene pramipexol o una de sus sales farmacéuticamente aceptable, un método para su fabricación y su uso
CL2008000058A1 (es) Formulacion que comprende un anticuerpo anti-il13, un criprotector, y una solucion amortiguadora; composicion farmaceutica que la comprende; metodo para tratar un trastorno relacionado con il13; y formas farmaceuticas que la comprenden.
BRPI0815766A2 (pt) Composição pesticida, e, método para potencializar a eficácia de um ingrediente ativo pesticida.
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
ATE429907T1 (de) Zusammensetzungen mit verzögerter freigabe enthaltend venlafaxinhydrochlorid als wirkstoff
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
DE122012000030I1 (de) Wirkstoffhaltige feste formkorper zur auserlichen anwendung gegen parasiten an tieren.
FR2891142B1 (fr) Composition cosmetique comprenant un compose organique du silicium, et procede de mise en forme des cheveux
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
BRPI0620345A2 (pt) composto, composição farmacêutica, uso de um composto, e, métodod para o tratamento de uma doença
AR065342A1 (es) Composiciones farmaceuticas que contienen fumarato de quetiapina
FR2891141B1 (fr) Composition cosmetique comprenant un compose organique du silicium, et procede de mise en forme des cheveux
EP1693062A3 (en) Androgen receptor-dependent gene expression control
NO20074676L (no) Krystallinske former av (1 RS, 3RS, 6RS)-6-dimetylaminometyl-1-(3-metoksy-fenyl)cykloheksan-1,3-diol hydroklorid
BRPI0820210A2 (pt) composto, composição farmacêutica, uso de um composto, e, método de tratamento terapêutico de um mamífero.
AR055072A1 (es) Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical